Impaired liver regeneration with humoral and genetic disturbances in urinary trypsin inhibitor-deficient mice

Liver International

Volumn 29, Issue 7, 2009, Pages 979-987

  Nobuoka, Takayuki ^a   Mizuguchi, Toru ^a   Oshima, Hideki ^a   Shibata, Toshihito ^a   Kaji, Shinsuke ^a   Nagayama, Minoru ^a   Meguro, Makoto ^a   Mitaka, Toshihiro ^b   Hirata, Koichi ^a  

^a SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Cytokine; Liver regeneration; Urinary trypsin inhibitor

Indexed keywords

BROXURIDINE; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; ULINASTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ANTIBODY FORMATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL4; CYTOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-6; LIVER; LIVER REGENERATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; TIME FACTORS;

EID: 67650504279     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.01990.x     Document Type: Article

References (39)

1. Baue AE, Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 1998; 10: 79-89.
2. Morita T, Togo S, Kubota T, et al. Mechanism of postoperative liver failure after excessive hepatectomy investigated using a cDNA microarray. J Hepatobiliary Pancreat Surg 2002; 9: 352-9.
3. Fry DE. Sepsis syndrome. Am Surg 2000; 66: 126-32.
4. Cryer HG. Advances in the understanding of multiple organ failure. Surg Infect 2000; 1: 165-70.
5. Schmidt SC, Hamann S, Langrehr JM, et al. Preoperative high-dose steroid administration attenuates the surgical stress response following liver resection: Results of a prospective randomized study. J Hepatobiliary Pancreat Surg 2007; 14: 484-92.
6. Pugia MJ, Lott JA. Pathophysiology and diagnostic value of urinary trypsin inhibitors. Clin Chem Lab Med 2005; 43: 1-16.
7. Lin SD, Endo R, Sato A, et al. Plasma and urine levels of urinary trypsin inhibitor in patients with acute and fulminant hepatitis. J Gastroenterol Hepatol 2002; 17: 140-7.
8. Tsujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: A randomized, controlled trial. Clin Gastroenterol Hepatol 2005; 3: 376-83.
9. Zimmermann A. Liver regeneration: The emergence of new pathways. Med Sci Monit 2002; 8: 53-63.
10. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006; 43: S45-53.
11. Fausto N, Riehle KJ. Mechanisms of liver regeneration and their clinical implications. J Hepatobiliary Pancreat Surg 2005; 12: 181-9.
12. Taub R. Liver regeneration: From myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-47.
13. Sato H, Kajikawa S, Kuroda S, et al. Impaired fertility in female mice lacking urinary trypsin inhibitor. Biochem Biophys Res Commun 2001; 281: 1154-60.
14. Akino K, Akita S, Mizuguchi T, et al. A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. J Surg Res 2005; 129: 142-6.
15. +T cells in the liver of patients with chronic HCV infection. J Hepatol 2006; 44: 475-83.
16. Mizuguchi T, Kamohara Y, Hui T, et al. Regulation of c-met expression in rats with acute hepatic failure. J Surg Res 2001; 99: 385-96.
17. Gallup JM, Kawashima K, Lucero G, et al. New quick method for isolating RNA from laser captured cells stained by immunofluorescent immunohistochemistry; RNA suitable for direct use in fluorogenic TaqMan one-step real-time RT-PCR. Biol Proced Online 2005; 7: 70-92.
18. Banus S, Pennings J, Vandebriel R, et al. Lung response to Bordetella pertussis infection in mice identified by gene-expression profiling. Immunogenetics 2007; 59: 555-64.
19. +T cells. J Immunol 2006; 176: 6202-10.
20. Fausto N. Involvement of the innate immune system in liver regeneration and injury. J Hepatol 2006; 45: 347-9.
21. Perry JK, Scott GK, Tse CA. Modulation of proliferation of cultured human cells by urinary trypsin inhibitor. Biochim Biophys Acta 1994; 1221: 145-52.
22. Manilal SB, Scott GK. Further evidence for the mitogenic action of urinary trypsin inhibitor. Biochem Mol Biol Int 1996; 39: 711-20.
23. Tsutsui H, Adachi K, Seki E, et al. Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003; 3: 545-59.
24. Leifeld L, Dumoulin FL, Purr I, et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 2003; 199: 335-44.
25. Bellido T, O'Brien CA, Roberson PK, et al. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 1998; 273: 21137-44.
26. Wüstefeld T, Rakemann T, Kubicka S, et al. Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology 2000; 32: 514-22.
27. Streetz KL, Luedde T, Manns MP, et al. Interleukin 6 and liver regeneration. Gut 2000; 47: 309-12.
28. Healy AM, Gelehrter TD. Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response. J Biol Chem 1994; 269: 19095-100.
29. Camargo Jr CA, Madden JF, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997; 26: 1513-20.
30. Matsumoto T, O'Malley K, Efron PA, et al. Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006; 140: 793-802.
31. Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappaB activation. Cell Growth Differ 1999; 10: 819-28.
32. Kaizu T, Ikeda A, Nakao A, et al. Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol 2008; 294: G236-44.
33. Tsoulfas G, Geller DA. NF-kappaB in transplantation: Friend or foe? Transpl Infect Dis 2001; 3: 212-9.
34. Nishiyama T, Aibiki M, Hanaoka K. The effect of ulinastatin, a human protease inhibitor, on the transfusion-induced increase of plasma polymorphonuclear granulocyte elastase. Anesth Analg 1996; 82: 108-12.
35. Bost F, Diarra-Mehrpour M, Martin JP. Inter-alpha-trypsin inhibitor proteoglycan family - a group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 1998; 252: 339-46.
36. Valatas V, Kolios G, Manousou P, et al. Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br J Pharmacol 2004; 141: 477-87.
37. Lentsch AB, Yoshidome H, Cheadle WG, et al. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology 1998; 27: 1172-7.
38. Dorman RB, Gujral JS, Bajt ML, et al. Generation and functional significance of CXC chemokines for neutrophil-induced liver injury during endotoxemia. Am J Physiol Gastrointest Liver Physiol 2005; 288: G880-6.
39. Stefanovic L, Brenner DA, Stefanovic B. Direct hepatotoxic effect of KC chemokine in the liver without infiltration of neutrophils. Exp Biol Med 2005; 230: 573-86.